These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 24566387

  • 1. Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
    He J, Wang Y, Kastin AJ, Pan W.
    Brain Behav Immun; 2014 May; 38():53-8. PubMed ID: 24566387
    [Abstract] [Full Text] [Related]

  • 2. Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease.
    Mazón Peláez I, Vogler S, Strauss U, Wernhoff P, Pahnke J, Brockmann G, Moch H, Thiesen HJ, Rolfs A, Ibrahim SM.
    Hum Mol Genet; 2005 Jul 15; 14(14):1977-89. PubMed ID: 15917267
    [Abstract] [Full Text] [Related]

  • 3. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS.
    J Neuroimmunol; 2008 Oct 15; 203(1):79-93. PubMed ID: 18687476
    [Abstract] [Full Text] [Related]

  • 4. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Tenorio G, Sauve Y, Kerr BJ.
    Exp Neurol; 2013 Mar 15; 241():113-21. PubMed ID: 23291347
    [Abstract] [Full Text] [Related]

  • 5. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice.
    Verbeek R, van Tol EA, van Noort JM.
    Biochem Pharmacol; 2005 Jul 15; 70(2):220-8. PubMed ID: 15946653
    [Abstract] [Full Text] [Related]

  • 6. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X, Qin X.
    Int J Mol Med; 2013 May 15; 31(5):1209-21. PubMed ID: 23525227
    [Abstract] [Full Text] [Related]

  • 7. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB, Horton JL, Chen Y.
    Cell Immunol; 1998 Sep 15; 188(2):118-24. PubMed ID: 9756642
    [Abstract] [Full Text] [Related]

  • 8. Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice.
    Raijmakers R, Vogelzangs J, Raats J, Panzenbeck M, Corby M, Jiang H, Thibodeau M, Haynes N, van Venrooij WJ, Pruijn GJ, Werneburg B.
    J Comp Neurol; 2006 Sep 10; 498(2):217-26. PubMed ID: 16856138
    [Abstract] [Full Text] [Related]

  • 9. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar 10; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 10. Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
    Dayger CA, Rosenberg JS, Winkler C, Foster S, Witkowski E, Benice TS, Sherman LS, Raber J.
    Pharmacol Biochem Behav; 2013 Feb 10; 103(4):860-8. PubMed ID: 23201649
    [Abstract] [Full Text] [Related]

  • 11. TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
    Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, De Chiara V, Bernardi G, Strata P, Centonze D.
    Exp Neurol; 2012 Oct 10; 237(2):296-303. PubMed ID: 22836148
    [Abstract] [Full Text] [Related]

  • 12. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Truong JJ, Kerr BJ.
    Pain; 2009 Jan 10; 141(1-2):156-64. PubMed ID: 19084337
    [Abstract] [Full Text] [Related]

  • 13. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
    Musgrave T, Benson C, Wong G, Browne I, Tenorio G, Rauw G, Baker GB, Kerr BJ.
    Brain Behav Immun; 2011 Nov 10; 25(8):1677-88. PubMed ID: 21723939
    [Abstract] [Full Text] [Related]

  • 14. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H.
    J Neurosci Res; 2008 Dec 10; 86(16):3548-55. PubMed ID: 18709652
    [Abstract] [Full Text] [Related]

  • 15. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system.
    Dutra RC, Moreira EL, Alberti TB, Marcon R, Prediger RD, Calixto JB.
    Brain Behav Immun; 2013 Oct 10; 33():90-101. PubMed ID: 23777652
    [Abstract] [Full Text] [Related]

  • 16. Altered cognitive-emotional behavior in early experimental autoimmune encephalitis--cytokine and hormonal correlates.
    Acharjee S, Nayani N, Tsutsui M, Hill MN, Ousman SS, Pittman QJ.
    Brain Behav Immun; 2013 Oct 10; 33():164-72. PubMed ID: 23886782
    [Abstract] [Full Text] [Related]

  • 17. Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice.
    Herrmann I, Kellert M, Spreer A, Gerber J, Eiffert H, Prinz M, Nau R.
    J Antimicrob Chemother; 2007 Jan 10; 59(1):74-9. PubMed ID: 17079237
    [Abstract] [Full Text] [Related]

  • 18. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
    Mattner F, Staykova M, Berghofer P, Wong HJ, Fordham S, Callaghan P, Jackson T, Pham T, Gregoire MC, Zahra D, Rahardjo G, Linares D, Katsifis A.
    J Nucl Med; 2013 Feb 10; 54(2):291-8. PubMed ID: 23321458
    [Abstract] [Full Text] [Related]

  • 19. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
    Musella A, Sepman H, Mandolesi G, Gentile A, Fresegna D, Haji N, Conrad A, Lutz B, Maccarrone M, Centonze D.
    Neuropharmacology; 2014 Apr 10; 79():567-72. PubMed ID: 24440366
    [Abstract] [Full Text] [Related]

  • 20. The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS).
    Bolton C, Scott GS, Smith T, Flower RJ.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):88-93. PubMed ID: 18977216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.